T30 for Astigmatism in Digital Device Users (T30FA)

April 19, 2024 updated by: Southern College of Optometry

Performance of Total30 for Astigmatism in Digital Device Users

This study aims to determine if Total30 lenses for astigmatism can be successfully fit in participants who are heavy digital device users.

Study Overview

Status

Active, not recruiting

Detailed Description

Extensive computer use is no longer an employment-specific challenge. Use of digital devices in work, home, and leisure settings is now the norm, and it is now socially expected. While the introduction of high-powered computers and digital devices have greatly improved many aspects of modern life, the pervasive use of digital devices has caused some patients to develop a condition known as Digital Eye Strain (DES). DES has been reported to be as high as 93% the population depending upon how the condition is defined, and its severity has been found to increase with increased digital device time. DES is a condition where patients experience symptoms such as glare, accommodative dysfunction, defocus, fatigue, discomfort, and dryness from digital device use, and these dry eye symptoms may also result in decreased quality of life. While dryness symptoms in DES are likely multifactorial (e.g., contact lens use, systemic disease status), much of the dryness symptoms in DES are probably due to tear film evaporation secondary to having a reduced number of blinks per minute while using digital devices.

Contact lens (CL) discomfort affects most CL wearers with discomfort consistently topping the reasons why established CL wearers drop out of CLs. In fact, studies have consistently found that the frequency of CL dropout is around 20% with this dropout frequency staying relatively stable over the past 20 plus years. This static frequency of CL dropout is surprising since there have been a number of dramatic soft CL innovations during this time frame (e.g., widely available daily disposable CLs, silicone hydrogel CL materials with high oxygen transmissibility, new CL surface coatings). CL discomfort and dropout could be affected by significant time spent on digital devices and DES. Maintaining ocular comfort with satisfactory CL performance (comfort, lack of dryness, and overall good vision) is key to overall success. This could be especially important in patients who wear astigmatic CLs, yet the community currently lacks data on this topic.

Study Type

Interventional

Enrollment (Estimated)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Kansas
      • Pittsburg, Kansas, United States, 66762
    • Mississippi
      • Coldwater, Mississippi, United States, 38618
        • Coldwater VIsion Center
        • Contact:
          • Kristopher May, OD
          • Phone Number: 662-224-8000
          • Email: kmay@sco.edu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adult (18- to 40-year-old)
  • 0.00 LogMAR visual acuity or better in their habitual CLs or by manifest refraction in both eyes
  • Smart phone with text messaging capabilities
  • Existing wearers of soft, frequent replacement toric CLs within past 6 months
  • Frequent digital device user (e.g., phone, iPad, computer, social media, video streaming, etc.) defined as at least 8 hours of usage per day
  • Willing to follow the required wear schedule
  • Astigmatism ranging from 0.75 D to 2.50 D in each eye
  • Willing to wear their CLs at least 13 hours/day

Exclusion Criteria: Have known systemic health conditions that are thought to alter tear film physiology (e.g., Sjögren's syndrome).

  • Have a known history of being diagnosed with dry eye disease
  • Have a history of ocular surgery within the past 12 months
  • Have a history of severe ocular trauma, active ocular infection or inflammation
  • Have a history of viral eye disease
  • Currently using isotretinoin-derivatives or ocular medications
  • Currently using a dry eye treatment including but not limited to artificial tears
  • Currently using rewetting drops daily or occasionally
  • If they are pregnant or breast feeding
  • Need for spectacle add power of any amount (presbyopic)
  • Currently wearing T30fA CLs
  • Have a history of wearing hard CLs
  • Subjects who show excessive lens oscillation with the T30fA lenses during the fitting process yet show 0.0 logMAR acuity, will be excluded from the study.
  • Patients who report unstable vision while wearing their habitual or study CLs (e.g., rotational instability of CLs)
  • Willing to not use any artificial tears or dry eye treatments during the study
  • Willing to not use rewetting drops during the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Total 30 for astigmatism contact lenses
Total30 for Astigmatism Monthly Replacement Contact Lenses
Participants must be refit into Total30 for Astigmatism Contact Lenses and wear them over the course of this one month study.
Other Names:
  • Lehfilcon A

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analog Scale (VAS) Comfort Scores
Time Frame: Baseline to 1 month of Contact lens wear
Participants will receive text message surveys on which they will record the comfort of their lenses throughout various points in the day, during different periods of the 1 month study. Scores will be recorded on a scale +/- 50 with +50 being the highest level of comfort and -50 being uncomfortable.
Baseline to 1 month of Contact lens wear

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 15, 2024

Primary Completion (Estimated)

August 15, 2024

Study Completion (Estimated)

August 18, 2024

Study Registration Dates

First Submitted

February 12, 2024

First Submitted That Met QC Criteria

February 12, 2024

First Posted (Actual)

February 20, 2024

Study Record Updates

Last Update Posted (Actual)

April 22, 2024

Last Update Submitted That Met QC Criteria

April 19, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRB00006733

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Refractive Errors

Clinical Trials on Total30 for Astigmatism Contact Lenses

3
Subscribe